← Oncology Approval Tracker

FDA DECISION ·

Xeloda + docetaxel

capecitabine plus docetaxel · Genentech

FDA approvalNew or expanded indicationBreast cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Combination with docetaxel for advanced or metastatic breast cancer progressing after an anthracycline-containing regimen.

LAMPGEN ANALYSIS

Why it matters

The revised combination indication specifies progression after anthracycline exposure.

What research teams should watch

Reconcile prior treatment and progression date, and track the separate administration schedules of both drugs.

PRIMARY RECORDS

Sources